logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. CenExel Sherman Oaks CA

Verified

Basic Information

Site Overview

Source: Human-provided.

CenExel CNR (California Neuroscience Research) is a specialized clinical research center within the nationwide CenExel network, focused primarily on neuroscience and central nervous system (CNS) clinical trials. Located in Sherman Oaks, California, the site has more than 20 years of experience conducting industry-sponsored studies and has established expertise in psychiatric and neurological disorders, including Alzheimer's disease, schizophrenia, major depressive disorder, anxiety disorders, insomnia, ADHD, migraine, and other CNS conditions. The site is led by experienced, board-certified investigators who have collectively participated in hundreds of Phase I–IV clinical trials and maintain strong affiliations with leading academic and healthcare institutions. As part of the CenExel network, CNR benefits from centralized operational support, advanced patient recruitment capabilities, standardized quality systems, and access to extensive research infrastructure. Its dedicated…

Source: Trial-derived.
20Total Trials
Source: Trial-derived.
8Recruiting Trials
Source: Trial-derived.
8Active Trials
Source: Trial-derived.
10Completed Trials
Source: Trial-derived.
19Unique Conditions
Source: Trial-derived.
13Unique Sponsors

Conditions

Source: Trial-derived. Depressive Disorder, Major (7)Source: Trial-derived. Major Depressive Disorder (3)Source: Trial-derived. Alzheimers Disease (2)Source: Trial-derived. Episodic Migraine (2)Source: Trial-derived. ADHD (1)Source: Trial-derived. Alzheimer Disease (1)Source: Trial-derived. Anhedonia (1)Source: Trial-derived. Anxiety (1)

Sponsors

Source: Trial-derived. Boehringer Ingelheim (3)Source: Trial-derived. Janssen Research & Development, LLC (3)Source: Trial-derived. Allergan (2)Source: Trial-derived. Hoffmann-La Roche (2)Source: Trial-derived. Intra-Cellular Therapies, Inc. (2)Source: Trial-derived. Xenon Pharmaceuticals Inc. (2)Source: Trial-derived. AbbVie (1)Source: Trial-derived. Naurex, Inc, an affiliate of Allergan plc (1)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. MRI
Source: AI-inferred. PET-CT

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Lumbar puncture
Source: AI-inferred. Radiopharmaceutical handling and administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Blood p-tau217 biomarker testing